FDA Approves Stem Cell Treatment for Dogs and Horses

A New FDA-approved clinical trial at Cornell University Hospital for Animals is exploring how stem cells can treat various musculoskeletal and neurological conditions in both dogs and horses. The trial focuses on using stem cells to help heal tissue, reduce inflammation, and manage pain in conditions like osteoarthritis, tendinopathy, and hip and elbow dysplasia.

The treatment’s potential extends beyond pets to equine patients. A horse named Leo, who was previously showing lameness at walking pace, has returned to soundness after receiving stem cell therapy for a soft tissue injury.

“The ultimate goal is to help animals recover from injuries more completely, and to reduce discomfort,” explains Dr. Aimee Colbath, who leads the equine component of the trial.

The findings from this research are particularly valuable as dogs and humans share many of the same musculoskeletal diseases and environmental factors, paving the way for exciting developments in both veterinary and human medicine.